Lumida
/NVO
⌘K
Novo Nordisk A/S

Novo Nordisk A/S

NVO
$43.07USD-2.14%-0.94 today

MARKET CAP

197.1B

P/E (TTM)

FWD P/E

DAY RANGE

$43 – $43

52W RANGE

$35
$64

AI Summary

Stalk
Sell NowMedium

NVO is in a Stage 4 decline with all EMAs sloping downward and price trading below key moving averages. The medium-term bias is bearish, reinforced by the Bearish Pivot Point pattern and resistance at the 50- and 200-day SMAs. Short-term momentum favors continued downside, so selling now into any rally toward the EMA/SMA cluster is advised.

  • Q1 2026 sales rose 32% to DKK 96.8 bn, with 62% GLP-1 market share.
  • High profitability and strong earnings yield support attractive valuation.
  • Lost 9% global GLP-1 share; Bernstein cut 2026 EPS forecasts 7% below consensus.
Full analysis →

Buying

9

institutions

Selling

6

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
CA

Citadel Advisors LLC

Q2 2026

SELL19.26 M923.18 M+-882.55 K+24.7%0.11%
FA

Fisher Asset Management, LLC

Q2 2026

SELL8.32 M399.10 M+-696.15 K+20.4%0.12%
MM

Millennium Management LLC

Q2 2026

BUY5.03 M240.91 M+2.00 M+116.6%0.09%
BI

Blackrock, Inc.

Q2 2026

BUY3.86 M185.11 M+909.83 K+70.7%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY3.64 M174.27 M+1.85 M+166.2%0.20%
RT

Renaissance Technologies LLC

Q2 2026

SELL3.03 M145.37 M+-364.70 K+16.4%0.20%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW2.62 M125.55 M+2.62 M+0.0%0.58%
JC

Jpmorgan Chase & Co

Q2 2026

SELL1.61 M77.94 M+-1.20 M-21.4%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY1.57 M75.10 M+133.38 K+42.6%0.12%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY1.52 M72.70 M+243.04 K+55.3%0.09%
FC

Farallon Capital Management LLC

Q1 2026

BUYNEW782.00 K28.74 M+782.00 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY324.15 K15.54 M+143.02 K+133.4%0.01%
EP

Eversept Partners, LP

Q2 2026

BUYNEW169.23 K8.11 M+169.23 K+0.0%0.42%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL40.00 K1.92 M+-6.00 K+13.4%0.09%
GM

Grantham, Mayo, Van Otterloo & Co. LLC

Q2 2026

SELL0.000.00+-27.97 K-100.0%0.00%